JP2003512836A5 - - Google Patents

Download PDF

Info

Publication number
JP2003512836A5
JP2003512836A5 JP2001533970A JP2001533970A JP2003512836A5 JP 2003512836 A5 JP2003512836 A5 JP 2003512836A5 JP 2001533970 A JP2001533970 A JP 2001533970A JP 2001533970 A JP2001533970 A JP 2001533970A JP 2003512836 A5 JP2003512836 A5 JP 2003512836A5
Authority
JP
Japan
Prior art keywords
acid
viability
cell
preferred
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001533970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003512836A (ja
Filing date
Publication date
Priority claimed from US09/427,154 external-priority patent/US6589725B1/en
Application filed filed Critical
Publication of JP2003512836A publication Critical patent/JP2003512836A/ja
Publication of JP2003512836A5 publication Critical patent/JP2003512836A5/ja
Pending legal-status Critical Current

Links

JP2001533970A 1999-10-25 2000-10-25 タンキラーゼh、細胞周期に関わる組成物および使用法 Pending JP2003512836A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/427,154 US6589725B1 (en) 1999-10-25 1999-10-25 Tankyrase H, compositions involved in the cell cycle and methods of use
US09/427,154 1999-10-25
PCT/US2000/041528 WO2001030987A2 (en) 1999-10-25 2000-10-25 Tankyrase h, compositions involved in the cell cycle and methods of use

Publications (2)

Publication Number Publication Date
JP2003512836A JP2003512836A (ja) 2003-04-08
JP2003512836A5 true JP2003512836A5 (enExample) 2007-12-06

Family

ID=23693704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001533970A Pending JP2003512836A (ja) 1999-10-25 2000-10-25 タンキラーゼh、細胞周期に関わる組成物および使用法

Country Status (6)

Country Link
US (2) US6589725B1 (enExample)
EP (1) EP1238063A2 (enExample)
JP (1) JP2003512836A (enExample)
AU (1) AU2470801A (enExample)
CA (1) CA2388332A1 (enExample)
WO (1) WO2001030987A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061813A1 (en) 1999-04-09 2000-10-19 Geron Corporation A second mammalian tankyrase
US6887675B1 (en) * 1999-10-25 2005-05-03 Rigel Pharmaceuticals, Inc. Tankyrase H, compositions involved in the cell cycle and methods of use
US20020142334A1 (en) * 2001-01-30 2002-10-03 Brown Janice A. Methods of detecting poly(ADP-ribose) polymerase enzymatic activity
US7059920B2 (en) * 2003-06-25 2006-06-13 International Connectors & Cable Corp. Spring clip connector
EP1836320A2 (en) * 2005-01-07 2007-09-26 Arqule, Inc. Compositions for modulation of parp and methods for screening for same
WO2009027650A1 (en) * 2007-08-24 2009-03-05 The Institute Of Cancer: Royal Cancer Hospital Materials and methods for exploiting synthetic lethality in brca-associated cancers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006123A1 (en) 1991-09-20 1993-04-01 Fred Hutchinson Cancer Research Center Human cyclin e
US5726025A (en) 1995-04-20 1998-03-10 President And Fellows Of Harvard College Assay and reagents for detecting inhibitors of ubiquitin-dependent degradation of cell cycle regulatory proteins
AU6956798A (en) 1997-04-10 1998-10-30 Genetics Institute Inc. Secreted expressed sequence tags (sests)
AUPO938897A0 (en) 1997-09-23 1997-10-16 Garvan Institute Of Medical Research A potential effector for the grb7 family of signalling proteins
US6277613B1 (en) 1998-06-10 2001-08-21 The Rockefeller University TRF1 binding protein, methods of use thereof
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
PL210415B1 (pl) 1999-01-11 2012-01-31 Agouron Pharma Pochodne indolu, środek farmaceutyczny i zastosowanie pochodnych indolu
WO2000061813A1 (en) 1999-04-09 2000-10-19 Geron Corporation A second mammalian tankyrase
WO2000072021A2 (en) 1999-05-26 2000-11-30 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
WO2000077225A1 (en) 1999-06-11 2000-12-21 Whitehead Institute For Biomedical Research A novel insulin signaling molecule
EP1192259A1 (en) 1999-06-29 2002-04-03 Icos Corporation Tankyrase2 materials and methods
US6455290B1 (en) 1999-07-09 2002-09-24 Pharmacia Italia S.P.A. Tankyrase homolog protein (THP), nucleic acids, and methods related to the same

Similar Documents

Publication Publication Date Title
Ragot et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice
ES2632345T3 (es) Inhibición de la señalización AXL en terapia antimetastásica
CN100506841C (zh) 将分子递送到细胞的方法和载体复合物
Michael et al. Signal sequences that target nuclear import and nuclear export of pre-mRNA-binding proteins
Luby-Phelps et al. Behavior of a fluorescent analogue of calmodulin in living 3T3 cells.
Jacquemin-Sablon et al. Nucleic acid binding and intracellular localization of unr, a protein with five cold shock domains
JPS61500646A (ja) ファクタ−8および関連生産物の製造
US20080009068A1 (en) Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
JP4430305B2 (ja) トランスフェクション複合体
JP2002330772A (ja) IgE依存性ヒスタミン放出因子(HRF)の受容体、HRF結合ペプチド及びこれらをコードする核酸、並びにこれらの用途
Loomis Cell‐cell adhesion in Dictyostelium discoideum
JP2003512836A5 (enExample)
JP2003512820A5 (ja) Syk−ubpタンパク質、組成物および使用法
US20060172300A1 (en) Method for identifying bhs-specific proteins and fragments thereof
CN103025341B (zh) 胰岛素样生长因子1受体结合肽
JP2003514548A5 (enExample)
EP1683866B1 (en) Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof
McCarthy et al. Protein composition of the hyaline layer of sea urchin embryos and reaggregating cells
US6413934B1 (en) Streptavidin mutants having secondary functional domains
EP4434533B1 (en) Artificial complex for tethering chromatids of chromosomes
US20030167129A1 (en) Binding compounds and methods for identifying binding compounds
US20030100519A1 (en) Using polyamide nucleic acid oligomers to engender a biological response
Harmon et al. Purification and partial characterization of ring-shaped miniparticles
WO1999020643A9 (en) Using polyamide nucleic acid oligomers to engender a biological response
US20050266498A1 (en) Method for screening biomolecule activity regulator